PLK1 is a critical determinant of tumor cell sensitivity to CPT11 and its inhibition enhances the drug antitumor efficacy in squamous cell carcinoma models sensitive and resistant...

por Zuco, Valentina, De Cesare, Michelandrea, Zaffaroni, Nadia, Lanzi, Cinzia, Cassinelli, Giuliana
Publicado en Oncotarget (2015)

Synergistic Antitumor Effects of Novel HDAC Inhibitors and Paclitaxel In Vitro and In Vivo

por Zuco, Valentina, De Cesare, Michelandrea, Cincinelli, Raffaella, Nannei, Raffaella, Pisano, Claudio, Zaffaroni, Nadia, Zunino, Franco
Publicado 2011

High efficacy of CpG-ODN, Cetuximab and Cisplatin combination for very advanced ovarian xenograft tumors

por Sommariva, Michele, de Cesare, Michelandrea, Meini, Alessandra, Cataldo, Alessandra, Zaffaroni, Nadia, Tagliabue, Elda, Balsari, Andrea
Publicado 2013

Effects of MnDPDP and ICRF-187 on Doxorubicin-Induced Cardiotoxicity and Anticancer Activity

por Kurz, Tino, Grant, Derek, Andersson, Rolf GG, Towart, Robertson, De Cesare, Michelandrea, Karlsson, Jan Olof G
Publicado 2012

Antitumor activity of miR-34a in peritoneal mesothelioma relies on c-MET and AXL inhibition: persistent activation of ERK and AKT signaling as a possible cytoprotective mechanism

por El Bezawy, Rihan, De Cesare, Michelandrea, Pennati, Marzia, Deraco, Marcello, Gandellini, Paolo, Zuco, Valentina, Zaffaroni, Nadia
Publicado en J Hematol Oncol (2017)

Efficacy of a Selective Binder of α(V)β(3) Integrin Linked to the Tyrosine Kinase Inhibitor Sunitinib in Ovarian Carcinoma Preclinical Models

por Sartori, Andrea, Corno, Cristina, De Cesare, Michelandrea, Scanziani, Eugenio, Minoli, Lucia, Battistini, Lucia, Zanardi, Franca, Perego, Paola
Publicado en Cancers (Basel) (2019)

CpG-oligodeoxynucleotides exert remarkable antitumor activity against diffuse malignant peritoneal mesothelioma orthotopic xenografts

por De Cesare, Michelandrea, Sfondrini, Lucia, Pennati, Marzia, De Marco, Cinzia, Motta, Valentina, Tagliabue, Elda, Deraco, Marcello, Balsari, Andrea, Zaffaroni, Nadia
Publicado en J Transl Med (2016)

Synthesis and Evaluation of the Tumor Cell Growth Inhibitory Potential of New Putative HSP90 Inhibitors

por Bizarro, Ana, Sousa, Diana, Lima, Raquel T., Musso, Loana, Cincinelli, Raffaella, Zuco, Vantina, De Cesare, Michelandrea, Dallavalle, Sabrina, Vasconcelos, M. Helena
Publicado en Molecules (2018)

Cellular Basis of Antiproliferative and Antitumor Activity of the Novel Camptothecin Derivative, Gimatecan, in Bladder Carcinoma Models

por Ulivi, Paola, Zoli, Wainer, Fabbri, Francesco, Brigliadori, Giovanni, Ricotti, Luca, Tesei, Anna, Rosetti, Marco, De Cesare, Michelandrea, Beretta, Giovanni L, Corna, Elisabetta, Supino, Rosanna, Zunino, Franco
Publicado 2005

Anti-tumor activity of selective inhibitors of XPO1/CRM1-mediated nuclear export in diffuse malignant peritoneal mesothelioma: the role of survivin

por De Cesare, Michelandrea, Cominetti, Denis, Doldi, Valentina, Lopergolo, Alessia, Deraco, Marcello, Gandellini, Paolo, Friedlander, Sharon, Landesman, Yosef, Kauffman, Michael G., Shacham, Sharon, Pennati, Marzia, Zaffaroni, Nadia
Publicado en Oncotarget (2015)

1,4-Substituted Triazoles as Nonsteroidal Anti-Androgens for Prostate Cancer Treatment

por Ferroni, Claudia, Pepe, Antonella, Kim, Yeong Sang, Lee, Sunmin, Guerrini, Andrea, Parenti, Marco Daniele, Tesei, Anna, Zamagni, Alice, Cortesi, Michela, Zaffaroni, Nadia, De Cesare, Michelandrea, Beretta, Giovanni Luca, Trepel, Jane B., Malhotra, Sanjay V., Varchi, Greta
Publicado en J Med Chem (2017)